"covid-19-recovered-patients"

The fresh allocation of the anti-fungal drug is in addition to the 890 vials that were released by the Centre on Friday.

Patients who continued to have respiratory symptoms, especially sore throat and rhinitis, were more likely to have a new positive test result.